ALA 4.35% 12.0¢ arovella therapeutics limited

Ann: SANOFI and SUDA Entered Into A Feasibility Agreement, page-2

  1. 2,934 Posts.
    lightbulb Created with Sketch. 472
    It's all happening! -

    "PERTH, AUSTRALIA – 9 December 2019: SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that it has entered into a feasibility agreement with SANOFI-AVENTIS GROUPE (SANOFI) to investigate the feasibility of SUDA’s OroMist Technology and SANOFI selected active ingredient.
    The agreement is for SUDA to carry out a fully-funded feasibility study that will terminate on March 30th, 2021. As a feasibility study, this study is not intended to generate significant revenue.
    Based on the outcomes of this feasibility study, SANOFI and SUDA may enter into further collaboration."

    .
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.005(4.35%)
Mkt cap ! $126.0M
Open High Low Value Volume
12.0¢ 13.0¢ 11.5¢ $320.8K 2.620M

Buyers (Bids)

No. Vol. Price($)
7 361972 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 521724 7
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
12.0¢
  Change
0.005 ( 9.09 %)
Open High Low Volume
12.0¢ 12.5¢ 12.0¢ 923098
Last updated 15.46pm 05/06/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.